Now, dial up your dose by twisting the middle round again until it locks
Your staff must be trained to educate and emphasize how to maximize the benefits of the oral medication while protecting outcomes and reputation
And you'll have to meet specific criteria, like having a body mass index (BMI) above a certain number
TOPLINE: A first-in-human study suggested that tirzepatide a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist modulated abnormal activity in the brains nucleus accumbens, thereby reducing food cravings and inducing weight loss in a patient with severe obesity
DPP-4 inhibitors like sitagliptin/Januvia) that indirectly boost GLP-1 by stopping its degradation, but those are a different class
Simple strategies such as adjusting eating habits, staying hydrated, and slowing dose increases can help manage symptoms